Neuronostics forms strategic partnership to deliver integrated EEG solutions for clinical trials 

Posted by 

SETsquared Bristol

Neuroelectrics, a pioneer in high-definition brain stimulation and EEG technology, has partnered with Neuronostics, an innovator in advanced digital biomarkers and EEG analysis, to deliver an integrated EEG solution tailored for the pharmaceutical, contract research organizations (CROs) and academic partners. This collaboration combines Neuroelectrics’ cutting-edge EEG hardware with Neuronostics’ proprietary analytics to streamline clinical trials and unlock new possibilities in neurological research.

A Game-Changing Collaboration
The partnership addresses a critical need in clinical trials for high-quality, actionable data by providing an integrated platform that accelerates research and improves outcomes. Leveraging Neuronostics’ proprietary BioEP tool and Neuroelectrics’ premium EEG technology, the platform enhances cohort identification, streamlines protocol design, and delivers precise EEG analysis, ensuring trials are both efficient and impactful.

John Terry, Managing Director at Neuronostics, stated:
“This collaboration with Neuroelectrics creates a powerful offering that will enable EEG and digital biomarkers to make clinical trials more efficient and effective, leading to significant benefits for people with neurological conditions.”

Ana Maiques, CEO of Neuroelectrics, commented:
“At Neuroelectrics, we believe in advancing brain health through innovation. Our partnership with Neuronostics elevates clinical trials by integrating the best in EEG technology and analytics, enabling breakthroughs in neurology and psychiatry.

The Power of Integrated EEG Solutions

Targeted Cohort Identification: The integrated EEG tool assists in identifying participants with the highest seizure burden through a brief 20-minute EEG. This targeted approach saves time and enhances statistical significance in trials.

Comprehensive Data Analysis: Certified neurophysiologists combine clinical expertise with Neuronostics’ cloud-based digital tools to deliver robust, actionable EEG insights tailored to trial objectives.

Optimized Protocol Design: Experts collaborate with sponsors to create trial protocols aligned with study goals, ensuring streamlined processes and reliable results.

Learn more about Neuronostics: neuronostics.com. 

Find out more about SETsquared Bristol’s incubation programme.  

Recent News, Blogs and Stories

Speakers Laura Gemmell and Andrew Smith at Startup Stories event

Startup Stories: From Idea to Exit

Bristol’s startup community came together recently for the fourth instalment of our SETsquared Bristol Startup Stories series, featuring two fireside chats exploring the founder journey - from the initial startup...
We're hiring

Two new job opportunities at SETsquared Bristol

We are recruiting for two job vacancies, a SETsquared Bristol Manager and an Entrepreneur in Residence. SETsquared Bristol is one of the region's pioneering tech incubators. Since its inception in...
GenomeKey blood sample in lab

Life Sciences spotlight: GenomeKey

Next-generation life sciences company, GenomeKey, was recently awarded $11.4m to transform sepsis diagnosis and treatment. We had a chat with CEO, Dr Michael Roberts, to hear his story… GenomeKey at...

SUCCESS IS THE GOAL

Fast track your technology business